Late filing
Filing comparison
Vitro Biopharma, Inc. told the SEC it could not file its quarterly report on time
Does not expect a significant change in results. Filed on the statutory due date.
(the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended July 31, 2026 by the original due date for such filing, without unreasonable effort or expense because it requires additional time to complete its financial statements. The Company expects that it will file the Form 10-Q no later than September 18, 2026.
Evidence
- Anticipates significant change
- No
- Days past due date
- 0
- Other periodic reports filed
- Yes
- Routine
- Yes
- Severity
- normal
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended July 31, 2026 by the original due date for such filing, without unreasonable effort or expense because it requires additional time to complete its financial statements. The Company expects that it will file the Form 10-Q no later than September 18, 2026.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.